相关实验视频
Updated: Jul 12, 2025

09:29
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
Published on: January 9, 2015
15.5K
强迫症障碍的血清素3受体对抗剂:一个系统的审查和对联的元分析
Shun Hamanaka1, Taro Kishi1, Kenji Sakuma1
1Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, 470-1192, Japan.
Journal of psychiatric research
|October 22, 2023
概括
血清素3受体对抗剂 (5-HT3R-As) 在治疗强迫症 (OCD) 中表现有前途,与安慰剂相比,显著改善症状. 由于研究规模较小,建议进行进一步的大规模试验.
科学领域:
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
- 临床试验 临床试验
背景情况:
- 血清素3受体对抗剂 (5-HT3R-As) 对强迫症 (OCD) 的疗效尚未得到充分证实.
- 现有的研究缺乏对双盲,随机,安慰剂对照试验 (DBRPCT) 的综合元分析.
研究的目的:
- 系统地审查和对评估强迫症治疗中5-HT3R-As的DBRPCT进行元分析.
- 评估5-HT3R-As对强迫症症状严重程度,治疗反应,缓解率和不良事件的影响.
主要方法:
- 对10个涉及628名参与者的DBRPCT进行了随机效应元分析.
- 结局包括耶鲁-布朗强迫症强迫性尺度 (Y-BOCS) 评分,治疗反应,缓解率,停药和不良事件.
- 计算了具有95%置信区间 (CI) 的平均差异 (MD) 和风险比率.
主要成果:
- 聚合的5-HT3R-As在降低Y-BOCS总分数 (MD = -5.08),痴迷和强迫子级分数,治疗反应和缓解率方面显著优于安慰剂.
- 与安慰剂相比,像granisetron,ondansetron和tropisetron这样的单个药物也显示了Y-BOCS总得分的显著改善.
- 在因任何原因停止治疗或在5-HT3R-As和安慰剂之间发生单个不良事件的发生率方面没有发现显著差异.
结论:
- 这一元分析表明,5-HT3R-As在改善强迫症症状方面是有效的.
- 这些发现支持了5-HT3R-As作为强迫症患者治疗选择的潜力.
- 更大的随机试验是有必要的,以证实这些发现,由于包含的研究中样本大小有限.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
254
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
254
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
410
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
410
Obsessive-Compulsive Disorder
131
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
131
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
272
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
272
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
217
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
217
Antidepressant Drugs: Overview
524
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
524

